123 related articles for article (PubMed ID: 8612550)
1. Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.
Yang NN; Bryant HU; Hardikar S; Sato M; Galvin RJ; Glasebrook AL; Termine JD
Endocrinology; 1996 May; 137(5):2075-84. PubMed ID: 8612550
[TBL] [Abstract][Full Text] [Related]
2. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
3. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW
J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401
[TBL] [Abstract][Full Text] [Related]
4. Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene.
Yang NN; Venugopalan M; Hardikar S; Glasebrook A
Science; 1996 Aug; 273(5279):1222-5. PubMed ID: 8703055
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
Grese TA; Pennington LD; Sluka JP; Adrian MD; Cole HW; Fuson TR; Magee DE; Phillips DL; Rowley ER; Shetler PK; Short LL; Venugopalan M; Yang NN; Sato M; Glasebrook AL; Bryant HU
J Med Chem; 1998 Apr; 41(8):1272-83. PubMed ID: 9548817
[TBL] [Abstract][Full Text] [Related]
6. Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.
Finkelman RD; Bell NH; Strong DD; Demers LM; Baylink DJ
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12190-3. PubMed ID: 1465458
[TBL] [Abstract][Full Text] [Related]
7. Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone.
Willson TM; Norris JD; Wagner BL; Asplin I; Baer P; Brown HR; Jones SA; Henke B; Sauls H; Wolfe S; Morris DC; McDonnell DP
Endocrinology; 1997 Sep; 138(9):3901-11. PubMed ID: 9275080
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
[TBL] [Abstract][Full Text] [Related]
9. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
Evans G; Bryant HU; Magee D; Sato M; Turner RT
Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
Black LJ; Sato M; Rowley ER; Magee DE; Bekele A; Williams DC; Cullinan GJ; Bendele R; Kauffman RF; Bensch WR
J Clin Invest; 1994 Jan; 93(1):63-9. PubMed ID: 8282823
[TBL] [Abstract][Full Text] [Related]
11. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.
Hughes DE; Dai A; Tiffee JC; Li HH; Mundy GR; Boyce BF
Nat Med; 1996 Oct; 2(10):1132-6. PubMed ID: 8837613
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.
Evans GL; Bryant HU; Magee DE; Turner RT
Endocrinology; 1996 Oct; 137(10):4139-44. PubMed ID: 8828469
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain.
Cyr M; Thibault C; Morissette M; Landry M; Di Paolo T
Neuropsychopharmacology; 2001 Aug; 25(2):242-57. PubMed ID: 11425508
[TBL] [Abstract][Full Text] [Related]
14. An estrogen receptor basis for raloxifene action in bone.
Bryant HU; Glasebrook AL; Yang NN; Sato M
J Steroid Biochem Mol Biol; 1999; 69(1-6):37-44. PubMed ID: 10418979
[TBL] [Abstract][Full Text] [Related]
15. The putative tumor suppressor deleted in malignant brain tumors 1 is an estrogen-regulated gene in rodent and primate endometrial epithelium.
Tynan S; Pacia E; Haynes-Johnson D; Lawrence D; D'Andrea MR; Guo JZ; Lundeen S; Allan G
Endocrinology; 2005 Mar; 146(3):1066-73. PubMed ID: 15564322
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of estrogen regulation of Hageman factor XII gene expression.
Farsetti A; Misiti S; Citarella F; Felici A; Andreoli M; Fantoni A; Sacchi A; Pontecorvi A
Endocrinology; 1995 Nov; 136(11):5076-83. PubMed ID: 7588244
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-β3 content in bone of female mice.
Anwar MJ; Radhakrishna KV; Sharma A; Vohora D
Eur J Pharm Sci; 2014 Oct; 62():219-26. PubMed ID: 24880111
[TBL] [Abstract][Full Text] [Related]
18. The effect of long-term ovarian hormone deficiency on transforming growth factor-beta and bone matrix protein mRNA expression in rat femora.
Westerlind KC; Wronski TJ; Evans GL; Turner RT
Biochem Biophys Res Commun; 1994 Apr; 200(1):283-9. PubMed ID: 8166696
[TBL] [Abstract][Full Text] [Related]
19. Ovariectomy decreases the mRNA levels of transforming growth factor-beta 1 and increases the mRNA levels of osteocalcin in rat bone in vivo.
Ikeda T; Shigeno C; Kasai R; Kohno H; Ohta S; Okumura H; Konishi J; Yamamuro T
Biochem Biophys Res Commun; 1993 Aug; 194(3):1228-33. PubMed ID: 8352780
[TBL] [Abstract][Full Text] [Related]
20. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
